These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 24693706)
1. [Pathogenesis of Parkinson's disease through LRRK2 mutation]. Ohta E; Obata F Seikagaku; 2014 Feb; 86(1):92-7. PubMed ID: 24693706 [No Abstract] [Full Text] [Related]
2. [Mutation in LRRK2 is associated with familial presentation of Parkinson's disease in a Chilean kindred]. Miranda M Rev Med Chil; 2007 Mar; 135(3):406-7. PubMed ID: 17505590 [No Abstract] [Full Text] [Related]
3. Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease. Greggio E Biochem Soc Trans; 2012 Oct; 40(5):1058-62. PubMed ID: 22988865 [TBL] [Abstract][Full Text] [Related]
4. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Cookson MR Nat Rev Neurosci; 2010 Dec; 11(12):791-7. PubMed ID: 21088684 [TBL] [Abstract][Full Text] [Related]
5. Dominant-negative effects of LRRK2 heterodimers: a possible mechanism of neurodegeneration in Parkinson's disease caused by LRRK2 I2020T mutation. Ohta E; Kawakami F; Kubo M; Obata F Biochem Biophys Res Commun; 2013 Jan; 430(2):560-6. PubMed ID: 23220480 [TBL] [Abstract][Full Text] [Related]
6. LRRK2 in Parkinson's disease: protein domains and functional insights. Mata IF; Wedemeyer WJ; Farrer MJ; Taylor JP; Gallo KA Trends Neurosci; 2006 May; 29(5):286-93. PubMed ID: 16616379 [TBL] [Abstract][Full Text] [Related]
7. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy. Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139 [TBL] [Abstract][Full Text] [Related]
9. LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease. Xiong Y; Dawson VL; Dawson TM Biochem Soc Trans; 2012 Oct; 40(5):1074-9. PubMed ID: 22988868 [TBL] [Abstract][Full Text] [Related]
10. The biology and pathobiology of LRRK2: implications for Parkinson's disease. Moore DJ Parkinsonism Relat Disord; 2008; 14 Suppl 2():S92-8. PubMed ID: 18602856 [TBL] [Abstract][Full Text] [Related]
11. [Advance of the study on LRRK2 gene in Parkinson's disease]. Zhang Y; Chen S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):657-9. PubMed ID: 19065525 [TBL] [Abstract][Full Text] [Related]
13. LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Esteves AR; Swerdlow RH; Cardoso SM Exp Neurol; 2014 Nov; 261():206-16. PubMed ID: 24907399 [TBL] [Abstract][Full Text] [Related]
14. LRRK2: both a cause and a risk factor for Parkinson disease? Foroud T Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895 [No Abstract] [Full Text] [Related]
15. An emerging role for LRRK2 in the immune system. Dzamko N; Halliday GM Biochem Soc Trans; 2012 Oct; 40(5):1134-9. PubMed ID: 22988878 [TBL] [Abstract][Full Text] [Related]
16. Lrrk2 in the limelight! Farrer MJ Neurology; 2007 Oct; 69(18):1732-3. PubMed ID: 17967990 [No Abstract] [Full Text] [Related]
17. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease. Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858 [TBL] [Abstract][Full Text] [Related]
18. The small GTPase activity of the ROC domain from LRRK2, a Parkinson's disease related protein. Fu QS; Song AX; Li SX; Hu HY Protein Pept Lett; 2009; 16(12):1442-6. PubMed ID: 20001906 [TBL] [Abstract][Full Text] [Related]